These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26304731)

  • 1. The biological complexity of urothelial carcinoma: Insights into carcinogenesis, targets and biomarkers of response to therapeutic approaches.
    Grivas PD; Melas M; Papavassiliou AG
    Semin Cancer Biol; 2015 Dec; 35():125-32. PubMed ID: 26304731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy.
    Grivas P; Yu EY
    Curr Treat Options Oncol; 2019 Jun; 20(8):67. PubMed ID: 31254108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects of upper tract urothelial carcinoma.
    Patel N; Arya M; Muneer A; Powles T; Sullivan M; Hines J; Kelly J
    Urol Oncol; 2014 Jan; 32(1):28.e11-20. PubMed ID: 23428541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper tract urothelial carcinoma: special considerations.
    Hutchinson R; Haddad A; Sagalowsky A; Margulis V
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):101-9. PubMed ID: 27057809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
    Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
    Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
    Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic targets in advanced urothelial carcinoma.
    Rouanne M; Loriot Y; Lebret T; Soria JC
    Crit Rev Oncol Hematol; 2016 Feb; 98():106-15. PubMed ID: 26589398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma.
    Li Q; Bagrodia A; Cha EK; Coleman JA
    Curr Urol Rep; 2016 Feb; 17(2):12. PubMed ID: 26757906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer: translating molecular genetic insights into clinical practice.
    Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
    Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the molecular pathology of urinary bladder tumors.
    Yousef PG; Gabril MY
    Pathol Res Pract; 2018 Jan; 214(1):1-6. PubMed ID: 29254798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical biomarkers for bladder cancer prognosis.
    Matsushita K; Cha EK; Matsumoto K; Baba S; Chromecki TF; Fajkovic H; Sun M; Karakiewicz PI; Scherr DS; Shariat SF
    Int J Urol; 2011 Sep; 18(9):616-29. PubMed ID: 21771101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
    J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deduction of Novel Genes Potentially Involved in Upper Tract Urothelial Carcinoma Using Next-Generation Sequencing and Bioinformatics Approaches.
    Lee HY; Chen YJ; Li CC; Li WM; Hsu YL; Yeh HC; Ke HL; Huang CN; Li CF; Wu WJ; Kuo PL
    Int J Med Sci; 2019; 16(1):93-105. PubMed ID: 30662333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
    van der Kwast TH; Bapat B
    Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of urothelial carcinoma.
    Miyazaki J; Nishiyama H
    Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of upper tract urothelial carcinoma.
    Lucca I; Leow JJ; Shariat SF; Chang SL
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):271-88, ix. PubMed ID: 25836934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Hsp90 in urothelial carcinoma.
    Chehab M; Caza T; Skotnicki K; Landas S; Bratslavsky G; Mollapour M; Bourboulia D
    Oncotarget; 2015 Apr; 6(11):8454-73. PubMed ID: 25909217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting advanced urothelial carcinoma-developing strategies.
    Alhalabi O; Rafei H; Shah A; Siefker-Radtke A; Campbell M; Gao J
    Curr Opin Oncol; 2019 May; 31(3):207-215. PubMed ID: 30844889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).
    Audenet F; Yates DR; Cussenot O; Rouprêt M
    Urol Oncol; 2013 May; 31(4):407-13. PubMed ID: 20884249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.